Holen Sie sich die Stockscreener-App
378.54
1.52%
-5.85
Handel nachbörslich:
382.00
3.46
+0.91%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$384.39
Offen:
$382.63
24-Stunden-Volumen:
2.35M
Relative Volume:
1.97
Marktkapitalisierung:
$83.98B
Einnahmen:
$76.39B
Nettoeinkommen (Verlust:
$7.81B
KGV:
13.02
EPS:
29.0772
Netto-Cashflow:
$7.93B
1W Leistung:
-3.94%
1M Leistung:
-12.94%
6M Leistung:
-25.53%
1J Leistung:
-0.03%
1-Tages-Spanne:
$376.51
$387.85
1-Wochen-Bereich:
$376.51
$401.66
52-Wochen-Spanne:
$330.00
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
378.54 | 85.27B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
175.32 | 14.92B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
194.36 | 12.65B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.57 | 11.62B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
105.85 | 10.45B | 6.07B | 793.80M | 464.40M | 5.9914 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
HCA Healthcare Nursing Research Day 2026 showcases nurse-led research that advances safer care - HCA Healthcare Today
HCA Healthcare to buy the College of Health Care Professions - The Business Journals
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Has $51.81 Million Position in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare Inc stock (US42225T1079): shares ease after recent gains as valuation comes into focu - AD HOC NEWS
Intech Investment Management LLC Grows Stock Position in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare Inc stock (US4041211033): shares steady as company moves to acquire The College of He - AD HOC NEWS
Truist Financial Maintains HCA Healthcare(HCA.US) With Buy Rating - Moomoo
HCA Healthcare Inc. stock underperforms Thursday when compared to competitors - MarketWatch
HCA Healthcare to Acquire CHCP to Strengthen Workforce Development - Yahoo Finance Singapore
Buying HCA at a Discount? You Are Getting Paid to Do It - Trefis
HCA Healthcare Agrees to Buy The College of Health Care Professions - Moomoo
HCA Healthcare to acquire College of Health Care Professions - Investing.com
HCA Healthcare Announces Agreement To Acquire The College Of Health Care Professions - TradingView
Texas school training 8,000 healthcare students a year is HCA’s next buy - Stock Titan
HCA Healthcare Announces Agreement to Acquire The College of Health Care Professions - Business Wire
Is HCA Undervalued? DCF Says Worth $765 - GuruFocus
Is HCA Healthcare Stock Utilizing Systematic Share Retirement for Long-Term Alpha? - Trefis
HCA Healthcare, Inc. (HCA) Stock Analysis: A Potential 29.66% Upside Amid Strong Analyst Confidence - DirectorsTalk Interviews
Philip Marchesini named HCA Florida Fawcett Hospital Chief Executive Officer - SRQ Magazine
HCA Healthcare’s SWOT analysis: stock gains momentum on guidance - Investing.com
Trading the Move, Not the Narrative: (HCA) Edition - Stock Traders Daily
Philip Marchesini named HCA Florida Fawcett Hospital chief executive officer - Florida Hospital News and Healthcare Report
HCA Healthcare (HCA) Is Down 6.8% After Q1 EBITDA Miss And Workforce Cuts Are Announced - Yahoo Finance
Stress Testing HCA: Historical Drawdowns and Macro Risks - Trefis
HCA Healthcare, Inc. $HCA Shares Sold by Rathbones Group PLC - MarketBeat
HCA Healthcare, Inc. $HCA Holdings Cut by Diamond Hill Capital Management Inc. - MarketBeat
HCA Stock Price, Quote & Chart | HCA HEALTHCARE INC (NYSE:HCA) - ChartMill
HCA Healthcare Stock Plummets -9.3% With 5-Day Losing Streak - Trefis
HCA Healthcare stock outlook: Is Wall Street bullish or bearish? - MSN
Stroke warning signs: HCA Healthcare stroke survivors share why it’s important to B.E. F.A.S.T. - HCA Healthcare Today
HCA Healthcare Inc. stock outperforms competitors despite losses on the day - MarketWatch
HCA Healthcare Stock Outlook: Is Wall Street Bullish or Bearish? - Yahoo Finance
HCA Virginia colleagues exceed volunteer goal, aid local communities - Yahoo
Banque Cantonale Vaudoise Lowers Stock Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
HCA: EBITDA headwinds from APTC expiration are manageable; growth and innovation initiatives remain on track - TradingView
HCA Healthcare Inc at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus
HCA Healthcare, Inc. $HCA Shares Sold by Resona Asset Management Co. Ltd. - MarketBeat
Nutex Health or HCA Healthcare: Which Stock Has More Upside? - Trefis
Fideuram Intesa Sanpaolo Private Banking S.P.A. Invests $5.50 Million in HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare vs Nutex Health: Which Stock Could Rally? - Trefis
Is HCA Healthcare Inc (HCA) a Bargain After 4.3% Drop? GF Value Says Undervalued - GuruFocus
HCA Healthcare Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
HCA Healthcare colleagues volunteer more than 41,800 hours during annual days of service initiative - HCA Healthcare Today
HCA shares fall as investors weigh workforce cuts and cost outlook ahead of conference appearance - Quiver Quantitative
HCA Healthcare (NYSE:HCA) Price Target Cut to $490.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
HCA Healthcare Colleagues Volunteer More Than 41,800 Hours During Annual Days of Service Initiative - The Joplin Globe
JPMorgan Adjusts Price Target on HCA Healthcare to $490 From $535, Maintains Neutral Rating - Moomoo
HCA Healthcare, Inc. $HCA Shares Sold by Maj Invest Holding A S - MarketBeat
Handelsbanken Fonder AB Boosts Position in HCA Healthcare, Inc. $HCA - MarketBeat
Will HCA’s (HCA) US$3 Billion Note Offering and Rising Risk Scrutiny Shift Its Financing Narrative? - Sahm
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.22%
1.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):